Outcome of immune checkpoint inhibitors in patients with extensive-stage small-cell lung cancer and brain metastases

Overview of attention for article published in Frontiers in oncology, May 2023

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 3 Mendeley

So far, Altmetric has seen 1 X post from an account with 6,531 followers.

New research: Outcome of immune checkpoint inhibitors in patients with extensive-stage small-cell lung cancer and brain metastases: Objectives Brain metastases (BMs) are common in extensive-stage small-cell lung cancer (SCLC) and are… #oncology https://t.

17 May 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.